Skip to main content
TipRanks
Go Ultimate75% OFF

Crispr Therapeutics AG (1CG) Q4 2019 Earnings Report

22 Followers

DE:1CG Q4 2019 EPS Results

Actual EPS
EUR 0.46
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.82

DE:1CG Q4 2019 Revenue Results

Actual Revenue
EUR 68.96M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+66870.43%

Earnings Announcement Details

Quarter
Q4 2019
Date
02/12/2020
Time
After Close
Conference Call
Wednesday, February 12, 2020
DE:1CG Upcoming Earnings

Crispr Therapeutics AG's next earnings date is estimated for February 16, 2027, based on past reporting schedules.

Q4 2019 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2019 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2019 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:1CG Earnings History

DE:1CG earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 16, 20272026 (Q4)-1.05--1.23――
Nov 02, 20262026 (Q3)-0.93-1.03-1.051.71% (+0.02)
Aug 03, 20262026 (Q2)-1.07-0.84-2.1560.83% (+1.31)
May 04, 20262026 (Q1)-1.09-1.15-1.4118.99% (+0.27)
Feb 12, 20262025 (Q4)-1.04-1.23-0.39-211.36% (-0.83)
Nov 10, 20252025 (Q3)-1.13-1.05-0.9-15.84% (-0.14)
Aug 04, 20252025 (Q2)-1.26-2.15-1.33-61.07% (-0.81)
May 06, 20252025 (Q1)-1.11-1.41-1.28-10.49% (-0.13)
Feb 11, 20252024 (Q4)-1.08-0.390.98-140.00% (-1.38)
Nov 05, 20242024 (Q3)-1.26-0.90-1.2628.37% (+0.36)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed